Heliox for prevention of morbidity and mortality in ventilated newborn infants

To determine the effect of Heliox on rates of mortality, neurodevelopmental impairment and bronchopulmonary dysplasia in ventilated infants and to evaluate the safety profile of heliox in this population.

Subgroups:

  1. Preterm infants
  2. Infants wtih evolving or established chronic lung disease

This is a protocol.

Share/Save